Article Details

FLEXcon Commercializes First-to-Market Hydrogel-Free Biosensing Electrode Technology

Retrieved on: 2022-11-14 22:12:10

Tags for this article:

Click the tags to see associated articles and topics

FLEXcon Commercializes First-to-Market Hydrogel-Free Biosensing Electrode Technology. View article details on hiswai:

Excerpt

It is an approved component in customer 510(k) and CE marked finished good medical devices. No hydrogel means a reduced chance of skin irritation for ...

Article found on: www.prweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up